Marine L Andersson

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. doi request reprint Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care
    M L Andersson
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden
    Eur J Clin Pharmacol 69:565-71. 2013
  2. doi request reprint A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele
    Marine L Andersson
    Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    Pharmacogenomics 13:757-62. 2012
  3. pmc Possible drug-drug interaction between quetiapine and lamotrigine--evidence from a Swedish TDM database
    Marine L Andersson
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden
    Br J Clin Pharmacol 72:153-6. 2011
  4. doi request reprint Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis
    Jonatan D Lindh
    Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Eur J Clin Pharmacol 65:365-75. 2009
  5. doi request reprint Seasonal variation in blood drug concentrations and a potential relationship to vitamin D
    Jonatan D Lindh
    Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, SE 141 86 Stockholm, Sweden
    Drug Metab Dispos 39:933-7. 2011
  6. doi request reprint Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin: author reply
    Marine L Andersson
    Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    Pharmacogenomics 13:1561-2. 2012

Detail Information

Publications6

  1. doi request reprint Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care
    M L Andersson
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden
    Eur J Clin Pharmacol 69:565-71. 2013
    ..To investigate the impact of the integration of the drug-drug interaction database SFINX into primary health care records on the prevalence of potentially serious drug-drug interactions...
  2. doi request reprint A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele
    Marine L Andersson
    Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    Pharmacogenomics 13:757-62. 2012
    ..Simvastatin interacts with warfarin, but the strength of the interaction varies between individual patients, indicating a genetic predisposition...
  3. pmc Possible drug-drug interaction between quetiapine and lamotrigine--evidence from a Swedish TDM database
    Marine L Andersson
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden
    Br J Clin Pharmacol 72:153-6. 2011
    ..The aim of the present study was to investigate a previously proposed interaction between quetiapine and lamotrigine resulting in reduced serum quetiapine concentrations...
  4. doi request reprint Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis
    Jonatan D Lindh
    Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Eur J Clin Pharmacol 65:365-75. 2009
    ..To quantify the influence of common cytochrome P450 2C9 (CYP2C9) polymorphisms on warfarin dose requirements...
  5. doi request reprint Seasonal variation in blood drug concentrations and a potential relationship to vitamin D
    Jonatan D Lindh
    Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, SE 141 86 Stockholm, Sweden
    Drug Metab Dispos 39:933-7. 2011
    ..Even though a causal relationship remains to be established, it is suggested that individual differences in vitamin D may contribute to variability in drug metabolism and disposition...
  6. doi request reprint Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin: author reply
    Marine L Andersson
    Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    Pharmacogenomics 13:1561-2. 2012
    ..A letter in response to: Botton MR, Hutz MA & Suarez-Kurtz G. Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin. Pharmacogenomics 13(14), 1557-1559 (2012)...